Detalhe da pesquisa
1.
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2-Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients.
Clin Infect Dis
; 77(5): 696-702, 2023 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078720